10Elms LLP’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

10Elms LLP’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.62M	Buy	64,472 +21,448	+50%	+$540K	0.69%	35
2026 Q1	$1.1M	Buy	43,024 +27,874	+184%	+$711K	0.69%	37
2025 Q4	$387K	Buy	15,150 +1,300	+9%	+$33.3K	0.35%	55
2025 Q3	$355K	Buy	13,850 +7,000	+102%	+$178K	0.32%	58
2025 Q2	$173K	Buy	6,850 +6,000	+706%	+$149K	0.16%	88
2025 Q1	$21.2K	Buy	+850	New	+$21K	0.02%	342

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

10Elms LLP's IBDX Position: Q2 2026 in Review

10Elms LLP increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 50% in Q2 2026, buying an estimated $540K and bringing the position to 64,472 shares worth $1.62M. The position accounts for 0.69% of the portfolio, ranked #35.

10Elms LLP first reported a position in IBDX in Q1 2025 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

10Elms LLP held 64,472 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.62M as of Q2 2026.
10Elms LLP bought 21,448 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $540K.
iShares iBonds Dec 2032 Term Corporate ETF made up 0.69% of 10Elms LLP's portfolio in Q2 2026, its #35 holding.
10Elms LLP first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on 10Elms LLP's 13F filing for Q2 2026, filed 14 Aug 2026.